CHRS Financials

Coherus Oncology Inc - Financial statements & key metrics

Stock Price

$1.99

Market Cap

$296.78M

EPS

$-1.56

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$28.51M

EPS (Diluted)

$0.25

Balance Sheet Highlights

Total Assets

$448.53M

Total Liabilities

$580.52M

Shareholders Equity

Cash & Equivalents

$125.99M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-20.44M

CapEx

Free Cash Flow

Profitability Metrics

Gross Margin

67.2%

Operating Margin

-3.4%

Net Margin

4.0%

ROE

0.3%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is CHRS revenue?

View CHRS's income statement for detailed revenue data.

Is CHRS profitable?

CHRS reported a profit of $28.51M in the most recent quarter. The net profit margin is 4.0%.

What is CHRS market cap?

CHRS has a market capitalization of $296.78M, making it a small-cap stock.

Does CHRS have debt?

View CHRS's balance sheet for debt information.

What is CHRS cash flow?

Cash flow data is available in the full financial statements.